cilostazol has been researched along with Pulmonary Embolism in 2 studies
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol was marketed first in Japan in 1988 and later in seven other countries for the treatment of chronic arterial occlusion." | 2.41 | [Research and development of cilostazol: an antiplatelet agent]. ( Kimura, Y; Nakagawa, K; Nishi, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 1 |
| Fukuta, Y | 1 |
| Higashino, R | 1 |
| Sato, R | 1 |
| Nomura, Y | 1 |
| Fukuda, Y | 1 |
| Ito, S | 1 |
| Takei, M | 1 |
| Kurimoto, T | 1 |
| Tamaki, H | 1 |
| Nishi, T | 1 |
| Kimura, Y | 1 |
| Nakagawa, K | 1 |
1 review available for cilostazol and Pulmonary Embolism
| Article | Year |
|---|---|
[Research and development of cilostazol: an antiplatelet agent].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arterial Occlusive Diseases; Cilostazol; Clinical Tria | 2000 |
1 other study available for cilostazol and Pulmonary Embolism
| Article | Year |
|---|---|
Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Cil | 1998 |